142 related articles for article (PubMed ID: 32912992)
1. Hokuriku-plus familial hypercholesterolaemia registry study: rationale and study design.
Tada H; Okada H; Yoshida S; Shimojima M; Nomura A; Tsuda T; Mori M; Takashima SI; Kato T; Usui S; Sakata K; Hayashi K; Fujino N; Inazu A; Takahara S; Imai Y; Matsubara T; Nohara A; Miwa K; Namura M; Terai H; Yoshida T; Araki T; Minamoto M; Aburao T; Ito Y; Nakanishi C; Kawasaki S; Todo Y; Koizumi J; Kita Y; Matsumoto H; Shintaku H; Hodatsu A; Ino H; Higashikata T; Takata M; Misawa K; Yamaguchi M; Noji Y; Osato K; Mabuchi T; Ichise T; Kaku B; Katsuda S; Fujimoto M; Uchiyama K; Fujioka K; Nakahashi T; Nozue T; Michishita I; Usuda K; Otowa K; Okeie K; Hirota S; Aburadani I; Kurokawa K; Takatori O; Hondo S; Oda H; Takata S; Murai H; Kinoshita M; Nagai H; Sekiguchi Y; Sakagami S; Omi W; Fujita C; Katsuki T; Ootsuji H; Igarashi A; Nakano M; Okura S; Maeno K; Mitamura Y; Sugimoto N; Yamamoto M; Akao H; Kajinami K; Takamura M; Kawashiri MA
BMJ Open; 2020 Sep; 10(9):e038623. PubMed ID: 32912992
[TBL] [Abstract][Full Text] [Related]
2. Impact of genetic testing on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia (GenTLe-FH): a randomised waiting list controlled open-label study protocol.
Nomura A; Tada H; Okada H; Nohara A; Ishikawa H; Yoshimura K; Kawashiri MA
BMJ Open; 2018 Dec; 8(12):e023636. PubMed ID: 30593551
[TBL] [Abstract][Full Text] [Related]
3. Prospective Registry Study of Primary Dyslipidemia (PROLIPID): Rationale and Study Design.
Tada H; Kurashina T; Ogura M; Takegami M; Miyamoto Y; Arai H; Harada-Shiba M; Ishibashi S
J Atheroscler Thromb; 2022 Jun; 29(6):953-969. PubMed ID: 34690220
[TBL] [Abstract][Full Text] [Related]
4. Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study.
Nakamura M; Uno K; Hirayama A; Ako J; Nohara A; Arai H; Harada-Shiba M
BMJ Open; 2017 Jul; 7(6):e014427. PubMed ID: 28674132
[TBL] [Abstract][Full Text] [Related]
5. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
6. A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort.
Pérez de Isla L; Watts GF; Muñiz-Grijalvo O; Díaz-Díaz JL; Alonso R; Zambón D; Fuentes-Jimenez F; Mauri M; Padró T; Vidal-Pardo JI; Barba MA; Ruiz-Pérez E; Michán A; Mediavilla JD; Hernandez AM; Romero-Jimenez MJ; Badimon L; Mata P;
Eur J Prev Cardiol; 2022 May; 29(5):795-801. PubMed ID: 34864959
[TBL] [Abstract][Full Text] [Related]
7. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
9. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
[TBL] [Abstract][Full Text] [Related]
10. Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia.
Besseling J; Reitsma JB; Gaudet D; Brisson D; Kastelein JJ; Hovingh GK; Hutten BA
Eur Heart J; 2017 Feb; 38(8):565-573. PubMed ID: 27044878
[TBL] [Abstract][Full Text] [Related]
11. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
[TBL] [Abstract][Full Text] [Related]
12. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
[TBL] [Abstract][Full Text] [Related]
13. Familial hypercholesterolaemia: a study protocol for identification and investigation of potential causes and markers of subclinical coronary artery disease in the Faroe Islands.
Borg SÁ; Nielsen MRS; Søgaard P; Lundbye-Christensen S; Jóanesarson J; Zaremba T; Kollslíð R; Schmidt EB; Joensen AM; Bork CS
BMJ Open; 2022 Apr; 12(4):e050857. PubMed ID: 35414540
[TBL] [Abstract][Full Text] [Related]
14. Familial Hypercholesterolemia Identification Algorithm in Patients with Acute Cardiovascular Events in A Large Hospital Electronic Database in Bulgaria: A Call for Implementation.
Petrov I; Postadzhiyan A; Vasilev D; Kasabov R; Tokmakova M; Nikolov F; Istatkov V; Zhao B; Mutafchiev D; Petkova R
Adv Ther; 2021 May; 38(5):2323-2338. PubMed ID: 33754300
[TBL] [Abstract][Full Text] [Related]
15. The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies.
Kayıkçıoğlu M; Tokgözoğlu L
Turk Kardiyol Dern Ars; 2017 Apr; 45(3):261-267. PubMed ID: 28429694
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry.
Bourbon M; Alves AC; Alonso R; Mata N; Aguiar P; Padró T; Mata P
Atherosclerosis; 2017 Jul; 262():8-13. PubMed ID: 28475941
[TBL] [Abstract][Full Text] [Related]
17. Search for familial hypercholesterolemia patients in an Italian community: A real-life retrospective study.
Fasano T; Trenti C; Negri EA; Guiducci V; Foracchia M; Bonelli E; Canovi S; Besutti G; Bertolini S; Calandra S
Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):577-585. PubMed ID: 35123858
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
Harada-Shiba M; Ako J; Arai H; Hirayama A; Murakami Y; Nohara A; Ozaki A; Uno K; Nakamura M
Atherosclerosis; 2018 Oct; 277():362-368. PubMed ID: 30270072
[TBL] [Abstract][Full Text] [Related]
19. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Lancet; 2021 Nov; 398(10312):1713-1725. PubMed ID: 34506743
[TBL] [Abstract][Full Text] [Related]
20. The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.
Al-Rasadi K; Alhabib KF; Al-Allaf F; Al-Waili K; Al-Zakwani I; AlSarraf A; Almahmeed W; AlSayed N; Alghamdi M; Batais MA; Almigbal TH; Alnouri F; Kinsara A; Hammouda A; Awan Z; Kary H; Elamin OA; Zadjali F; Al-Jarallah M; Shehab A; Sabbour H; Amin H; Altaradi H
Curr Vasc Pharmacol; 2020; 18(1):57-64. PubMed ID: 30289081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
